Victor Alfonso Jimenez Diaz
Cardiology — University Hospital Complex Of Vigo, Spain
VICTOR ALFONSO JIMENEZ DIAZ
LeadR Profile
Cardiology
Subspecialties: Surgery - Thoracic And Cardiovascular Surgery - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2017 - 2026
Number : 75
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
Clinical Studies 23
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
5 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| A Placebo Controlled Phase 3 Study to Evaluate the Effect of 10 mg Obicetrapib in Participants With Atherosclerotic Cardiovascular Disease (ASCVD) Whose Current Treatment with Lipid Modifying Therapies is not Sufficiently Effective 2023-507795-51-00 — blood, heart, cardiovascular diseases, arteries, plague, therapeutics, blood vessels, lipids | Phase 3 | Active not recruiting | 2022 |
| OCEAN(a) CCTA Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction Coronary Computed Tomography Angiography trial 2025-521117-88-00 — safety, tomography, lipoproteins, cardiovascular diseases, multiple chronic conditions, angiography, arteries, lipoprotein(a), computed tomography angiography | Phase 3 | Recruiting | 2026 |
| Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants with Atherosclerotic Cardiovascular Disease and Overweight or Obesity (MARITIME CV) 2024-516652-18-00 — cardiovascular diseases, obesity, therapeutics, overweight | Phase 3 | Recruiting | 2025 |
| A Trial to Test How AZD0780 Affects Serious Heart Stroke or Vascular Problems in Patients with Heart Stroke or Vascular Disease or at High Risk for Such Issues 2025-520519-14-00 — stroke, heart, cardiovascular diseases, vascular diseases | Phase 3 | Recruiting | 2025 |
| Safety and Effectiveness of the Crystalline Sirolimus Eluting Device in Patients With Coronary Artery Disease NCT07444957 — safety, coronary artery disease, myocardial infarction, pharmaceutical preparations, sirolimus, arteries, st elevation myocardial infarction, angina, stable, therapeutics, non-st elevated myocardial infarction, ischemia, angina, unstable | N/A | Recruiting | 2026 |
LeadR Networks
Main global connection map